The Valley Desk

NCT03263091 · Interventional trial

Efficacy and Safety of Roxadustat for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome With Low Red Blood Cell Transfusion Burden

Overall registry status Terminated

Phase 3

Conditions Anemia, Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov